NO311026B1 - Benzoxazinforbindelser, mellomprodukter for fremstilling av forbindelsene, anvendelse av forbindelsene samt farmasoytiskepreparater inneholdende disse og fremgangsmater for fremstillingav mellomprodukter og sluttprodukt - Google Patents

Benzoxazinforbindelser, mellomprodukter for fremstilling av forbindelsene, anvendelse av forbindelsene samt farmasoytiskepreparater inneholdende disse og fremgangsmater for fremstillingav mellomprodukter og sluttprodukt Download PDF

Info

Publication number
NO311026B1
NO311026B1 NO19982071A NO982071A NO311026B1 NO 311026 B1 NO311026 B1 NO 311026B1 NO 19982071 A NO19982071 A NO 19982071A NO 982071 A NO982071 A NO 982071A NO 311026 B1 NO311026 B1 NO 311026B1
Authority
NO
Norway
Prior art keywords
dihydro
oxo
ethyl
benzoxazine
phenoxy
Prior art date
Application number
NO19982071A
Other languages
English (en)
Norwegian (no)
Other versions
NO982071D0 (no
NO982071L (no
Inventor
Roger Frechette
Michele A Weidner-Wells
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO982071D0 publication Critical patent/NO982071D0/no
Publication of NO982071L publication Critical patent/NO982071L/no
Publication of NO311026B1 publication Critical patent/NO311026B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19982071A 1995-11-07 1998-05-06 Benzoxazinforbindelser, mellomprodukter for fremstilling av forbindelsene, anvendelse av forbindelsene samt farmasoytiskepreparater inneholdende disse og fremgangsmater for fremstillingav mellomprodukter og sluttprodukt NO311026B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/553,188 US5696117A (en) 1995-11-07 1995-11-07 Benzoxazine antimicrobial agents
PCT/US1996/016669 WO1997017333A1 (en) 1995-11-07 1996-10-17 Benzoxazine antimicrobial agents

Publications (3)

Publication Number Publication Date
NO982071D0 NO982071D0 (no) 1998-05-06
NO982071L NO982071L (no) 1998-06-05
NO311026B1 true NO311026B1 (no) 2001-10-01

Family

ID=24208465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982071A NO311026B1 (no) 1995-11-07 1998-05-06 Benzoxazinforbindelser, mellomprodukter for fremstilling av forbindelsene, anvendelse av forbindelsene samt farmasoytiskepreparater inneholdende disse og fremgangsmater for fremstillingav mellomprodukter og sluttprodukt

Country Status (24)

Country Link
US (2) US5696117A (hu)
EP (1) EP0869949B1 (hu)
JP (1) JP2000500134A (hu)
KR (1) KR100503910B1 (hu)
AR (1) AR004706A1 (hu)
AT (1) ATE229944T1 (hu)
AU (1) AU720743B2 (hu)
BR (1) BR9611400A (hu)
CZ (1) CZ137998A3 (hu)
DE (1) DE69625515T2 (hu)
DK (1) DK0869949T3 (hu)
ES (1) ES2188795T3 (hu)
HU (1) HUP9901184A3 (hu)
IL (1) IL124337A (hu)
MX (1) MX9803650A (hu)
MY (1) MY128650A (hu)
NO (1) NO311026B1 (hu)
NZ (1) NZ321251A (hu)
PL (1) PL189987B1 (hu)
RU (1) RU2191179C2 (hu)
SK (2) SK285388B6 (hu)
TW (1) TW536537B (hu)
WO (1) WO1997017333A1 (hu)
ZA (1) ZA969326B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812770A (pt) 1997-10-27 2000-12-12 Reddy Research Foundation Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
US6265401B1 (en) * 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
AU6762400A (en) * 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
WO2001087860A2 (en) * 2000-05-12 2001-11-22 Ortho-Mcneil Pharmaceutical, Inc. Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
AU2001261503A1 (en) * 2000-05-12 2001-11-26 Ortho-Mcneil Pharmaceutical, Inc. Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
PT1280784E (pt) 2000-05-12 2007-09-03 Ortho Mcneil Pharm Inc 4h-benzo [1,4] oxazin-3-onas biologicamente activas.
US6908908B2 (en) 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050266575A1 (en) * 2004-05-27 2005-12-01 Mayo Kevin H Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
WO2006082495A1 (en) * 2005-02-02 2006-08-10 Ranbaxy Laboratories Limited Peroxisome proliferator activated receptor modulators
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP1985297A1 (en) * 2006-01-27 2008-10-29 Japan Tobacco, Inc. Carboxylic acid compound and use thereof
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
JP5099814B2 (ja) * 2006-02-02 2012-12-19 田辺三菱製薬株式会社 含窒素複素二環式化合物
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
TWI410410B (zh) 2007-08-10 2013-10-01 Ono Pharmaceutical Co Phenylacetic acid compounds
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
CA2757729A1 (en) * 2009-04-14 2010-10-21 Masanori Kai Haloalkylsulfonanilide derivative
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US9493452B2 (en) 2011-03-24 2016-11-15 Southern Methodist University Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
US8669363B2 (en) 2011-03-24 2014-03-11 Southern Methodist University Quinoxaline compounds and derivatives
WO2013142831A1 (en) 2012-03-23 2013-09-26 Southern Methodist University Methods of making and using thioxothiazolidine and rhodanine derivatives as hiv-1 and jsp-1 inhibitors
GB2533925A (en) * 2014-12-31 2016-07-13 Univ Bath Antimicrobial compounds, compositions and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635956A (en) * 1968-03-01 1972-01-18 Squibb & Sons Inc Benzothiazines related compounds derivatives and salts thereof
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
JPS5547006B2 (hu) * 1973-04-04 1980-11-27
FR2588868B1 (fr) * 1985-10-21 1988-11-10 Negma Laboratoires Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use
DE4304806A1 (de) * 1993-02-17 1994-08-18 Kali Chemie Pharma Gmbh 5-Phenyl-pyrrolo-1,4-benzoxazin- und -thiazin-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
ATE229944T1 (de) 2003-01-15
ZA969326B (en) 1998-05-06
DE69625515D1 (de) 2003-01-30
DE69625515T2 (de) 2003-05-15
MY128650A (en) 2007-02-28
TW536537B (en) 2003-06-11
NZ321251A (en) 1999-10-28
SK283888B6 (sk) 2004-04-06
NO982071D0 (no) 1998-05-06
US5854242A (en) 1998-12-29
AR004706A1 (es) 1999-03-10
IL124337A0 (en) 1998-12-06
BR9611400A (pt) 1999-08-31
PL189987B1 (pl) 2005-10-31
PL326704A1 (en) 1998-10-26
HUP9901184A3 (en) 2001-11-28
SK285388B6 (sk) 2006-12-07
EP0869949B1 (en) 2002-12-18
DK0869949T3 (da) 2003-03-31
HUP9901184A2 (hu) 1999-10-28
US5696117A (en) 1997-12-09
AU7451996A (en) 1997-05-29
AU720743B2 (en) 2000-06-08
IL124337A (en) 2001-08-08
SK59798A3 (en) 1999-09-10
MX9803650A (es) 1998-11-30
CZ137998A3 (cs) 1998-10-14
KR19990067395A (ko) 1999-08-16
EP0869949A1 (en) 1998-10-14
JP2000500134A (ja) 2000-01-11
WO1997017333A1 (en) 1997-05-15
RU2191179C2 (ru) 2002-10-20
KR100503910B1 (ko) 2005-12-29
NO982071L (no) 1998-06-05
ES2188795T3 (es) 2003-07-01

Similar Documents

Publication Publication Date Title
NO311026B1 (no) Benzoxazinforbindelser, mellomprodukter for fremstilling av forbindelsene, anvendelse av forbindelsene samt farmasoytiskepreparater inneholdende disse og fremgangsmater for fremstillingav mellomprodukter og sluttprodukt
US5707990A (en) 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
US5773469A (en) Diaryl antimicrobial agents
NZ328900A (en) Substituted phenyl or pyridyl substituted phenyl, benzo[b]furan or indolyl derivatives and medicaments
NO175256B (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-oksokinolin-3-karboksylsyrederivater
HU213113B (en) Process for producing 2-aminobenzoxazole and 2-amino-benzothiazole derivatives and pharmaceutical compositions containing them
JPH09194478A (ja) 2−オキソ−および2−チオ−1,2−ジヒドロキノリニル−オキサゾリジノン類
IE861724L (en) Isoxazole and furan derivatives
CA2446120A1 (en) Novel arylheteroalkylamine derivatives
Mayekar et al. Synthesis and antimicrobial study of new 8-bromo-1, 3-diaryl-2, 3-dihydro-1H-naphtho [1, 2e][1, 3] oxazines
CA3166358A1 (en) Small molecule sting antagonists
AU784314B2 (en) Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
EP2955174A1 (en) Derivative of homoserine lactone, and preparation method and use thereof
JP2016507536A (ja) 新規な細菌体密度感知制御剤及びその医療用途
Agrawal et al. 4-Thiazolidinone and 1-thia-3, 4, 9-triaza fluorene conjugates: synthesis, characterization and antimicrobial screening
Kumar et al. An efficient synthesis of 2-(1-methyl-1, 2, 5, 6-tetrahydropyridin-3-yl) morpholine: a potent M1 selective muscarinic agonist
CA2236928A1 (en) Benzoxazine antimicrobial agents
Ayyash Design and Synthesis of Novel Bis Thiazolo [4, 5-c] Isoxazolines Bearing 1, 2, 4-triazole Ring Derived From the Related 4-thiazolidinons as Antimicrobial Agents
Yang et al. Synthesis and in vitro antimicrobial activity of benzo [b][1, 4] thiazin-3 (4 H)-ones via smiles rearrangement
KR100814098B1 (ko) 히스톤 디아세틸라제 저해활성을 갖는 알킬아미노나프탈렌일옥시 메틸옥트 n-하이드록시엔아마이드 유도체,이의 제조방법 및 이를 유효성분으로 하는 항암제용 약학조성물
Butin et al. Aryl ring migration reaction in the synthesis of 2, 4-diaryl-4H-3, 1-benzothiazines
Udhayasurian et al. Facile NMI-MsCl mediated synthesis of novel pyrazole derivatives bearing heteroaryl amides as potent antimicrobial agents
Shaaban et al. Synthesis and antibacterial activity of novel quinoxalinone derivatives
ALDEHYDE PHARMA SCIENCE MONITOR
WO2007092961A2 (en) Antibacterial agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees